SULT1C2P2

Across TCGA pan-cancer cohorts, SULT1C2P2 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated SULT1C2P2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SULT1C2P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SULT1C2P2 expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

LUSC, THYM, and ACC are the cancer types where SULT1C2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.170	0.393	.019	30	view →
THYM	OS	Tertile	All	0.911	0.984	.005	27	view →
ACC	DFS	Tertile	All	0.057	0.623	.001	27	view →
STAD	OS	Median	IV	0.642	0.194	.003	22	view →
TGCT	DFS	Tertile	II,III,IV	0.621	0.949	.034	18	view →
UCEC	OS	Quartile	All	0.435	0.801	.005	18	view →
LIHC	OS	Quartile	II,III,IV	0.525	0.805	.009	14	view →
KIRP	DFS	Tertile	III,IV	0.282	0.796	.021	11	view →
LUAD	OS	Quartile	All	0.796	0.624	.013	11	view →
ESCA	OS	Median	All	0.629	0.940	.026	9	view →
KIRC	DFS	Tertile	All	0.804	0.910	.012	7	view →
SARC	DFS	Tertile	All	0.352	0.529	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

SULT1C2P2–LUSC (DFS)

Open the LUSC breakdown →